Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)-Reference-Cited by-同舟云学术

Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)

Published:2022-06 Issue:3 Volume:165 Page:637-641
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Henno S.,Jeanne C.,Rouge T. De La Motte,Genestie C.,Treilleux I.,Croce S.,Just P.A.,Le Frere-Belda M.A.,Guinaudeau E.,Penault-Llorca F.,Arnould L.,Mery-Lamarche E.,Leroux A.,Lemaire A.S.,Averous G.,Renaud O.,Charafe-Jauffret E.,Bonneau C.,Leaha C.,Ray-Coquard I.,Devouassoux-Shisheboran M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference30 articles.

1. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence;Cabasag;Int. J. Cancer,2020

2. IARC (Lyon) 5th Edition;WHO Classification of Female Genital Tract Tumors,2020

3. Networking for ovarian rare tumors: a significant breakthrough improving disease management;Chiannilkulchai;Ann. Oncol.,2017

4. GINECO group. Management of rare ovarian cancers: the experience of the French website “Observatory for rare malignant tumours of the ovaries” by the GINECO group: interim analysis of the first 100 patients;Ray-Coquard;Gynecol. Oncol.,2010

5. Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France;Ray-Coquard;Bull. Cancer,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of Molecular Pathology for the Diagnosis of Sex Cord–Stromal Tumors of the Ovary: A Narrative Review;Cancers;2023-12-15

2. Gynecological carcinosarcomas: Overview and future perspectives;Bulletin du Cancer;2023-11

3. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma;Journal of Experimental & Clinical Cancer Research;2023-10-07

4. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study;Gynecologic Oncology;2023-07

5. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group;Gynecologic Oncology;2022-11